More doses of Covid-19 vaccines have been delivered to the EU, the UK and the United States in the six-week run up to Christmas than African countries have received all year, new analysis from the People’s Vaccine Alliance reveals today.

In reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool, People’s Vaccine Alliance spokesperson and Oxfam America’s Senior Advocacy Advisor, Robbie Silverman, said: “Pfizer’s announcement to voluntarily licence the COVID treatment Paxlovid is welcome but is far from enough." 
 
 

New figures from the Peoples Vaccine Alliance reveal that the companies behind two of the most successful COVID vaccines – Pfizer, BioNTech and Moderna – are making combined profits of $65,000 every minute. The figures based on the latest company reports are released as CEOs from pharmaceutical industry meet for the annual STAT summit —the equivalent of a ‘Big Pharma Davos’— from 16-18 November.

In response to the announcement that AstraZeneca is to move away from the non-profit model for COVID vaccines, Anna Marriott, Oxfam’s Health Policy Manager and spokesperson for the People’s Vaccine Alliance, said: “AstraZeneca is breaking its repeated and celebrated public promises of a non-profit vaccine for all countries for the duration of this pandemic and to never to make a profit in any low- and middle-income country from this publicly funded vaccine."
 

An international coalition of human rights law groups, public health experts, and civil society organisations is taking legal action against the US, UK, Germany, Norway, and Switzerland, on the grounds that these countries are in violation of international human rights law by failing to intervene on what has been an inequitable and racially discriminatory rollout of the vaccine and other COVID healthcare technologies. 

In response to the announcement that the World Health Organisation (WHO) has granted emergency use license for the COVID-19 vaccine, Covaxin, developed by Bharat Biotech in India, People’s Vaccine Alliance spokesperson and Oxfam Health Policy Manager, Anna Marriott, said: "Another approved vaccine to fight COVID-19 is fantastic news. We strongly encourage Bharat Biotech to show pandemic leadership and do the right thing for humanity by agreeing to share the vaccine technology and rights with the WHO's COVID Technology Access Pool, so that more manufacturers around the world can produce them.

At the end of the G20 Summit in Rome, Italy, Oxfam panned the lack of bold and effective action from the world leaders at such an important moment in the global response to the COVID-19 pandemic. 

Ahead of the G20 Summit in Rome, Italy, Oxfam calls on G20 leaders to take urgent action to dramatically scale up manufacturing and access to COVID-19 vaccines around the world, promote a fair economic recovery, fight hunger, lower dangerous greenhouse gas emissions, and help the poorest countries adapt to the climate change already happening.

Developing countries have been hit with an endless tide of inadequate gestures and broken promises from rich countries and pharmaceutical companies, who are failing to deliver billions of doses they promised while blocking the real solutions to vaccine inequality, according to a new report published today by the People’s Vaccine Alliance. 

On the eve of President Biden’s global COVID-19 summit on the side-lines of the UN General Assembly, campaigners from the People’s Vaccine Alliance are calling for world leaders to go beyond empty promises of charity and deliver bold action to increase manufacturing and access to COVID-19 vaccines around the world.